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Probiotics have shown positive effects on gastrointestinal diseases; they have barrier-modulating effects and change the
inflammatory response towards pathogens in studies in vitro. The aim of this investigation has been to examine the response of
intestinal epithelial cells to Enterococcus faecium NCIMB 10415 (E. faecium), a probiotic positively affecting diarrhea incidence in
piglets, and two pathogenic Escherichia coli (E. coli) strains, with specific focus on the probiotic modulation of the response to the
pathogenic challenge. Porcine (IPEC-J2) and human (Caco-2) intestinal cells were incubated without bacteria (control), with E.
faecium, with enteropathogenic (EPEC) or enterotoxigenic E. coli (ETEC) each alone or in combination with E. faecium. The ETEC
strain decreased transepithelial resistance (TER) and increased IL-8 mRNA and protein expression in both cell lines compared
with control cells, an effect that could be prevented by pre- and coincubation with E. faecium. Similar effects were observed for
the increased expression of heat shock protein 70 in Caco-2 cells. When the cells were challenged by the EPEC strain, no such
pattern of changes could be observed. The reduced decrease in TER and the reduction of the proinflammatory and stress response
of enterocytes following pathogenic challenge indicate the protective effect of the probiotic.
1. Introduction
Probiotic bacteria have been shown to have positive effects
on hosts with intestinal diseases such as Clostridium difficile-,
Rotavirus-, and Escherichia coli-induced diarrhea and also in
the prevention of antibiotic-associated diarrhea and nosoco-
mial infections [1–5]. According to the WHO, probiotics are
defined as live organisms that, when ingested in sufficient
amounts, have a beneficial effect on the overall health of
the host [6]. In animal nutrition, probiotics are used as feed
additives with positive effects regarding health and growth
performance traits [7–9].
The probiotic Enterococcus faecium NCIMB 10415 (E.
faecium) is licensed as a feed additive for sows and piglets
and has been demonstrated to reduce diarrhea incidence and
severity in weaning piglets [10, 11]. In human medicine, E.
faecium is used successfully in the treatment of acute diar-
rheal diseases and in the prevention of antibiotic-associated
diarrhea [12, 13]. However, the crosstalk between the probi-
otic and other microorganisms and between the probiotic
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and epithelial and immune cells of the intestinal wall is
extremely complex [14, 15], and many of the underlying
signaling mechanisms are still only partially understood.
In vivomodels of gastrointestinal infections have demon-
strated a positive effect of various probiotic feed additives on
the functional barrier of the intestine [16–18]. These results
are supported by data from in vitro cell culture infection
models in which probiotic strains prevent or ameliorate
damage to epithelial integrity by a pathogenic challenge [19,
20]. Furthermore, the immunological response of themucosa
can be influenced by probiotic strains, which modulate the
release of cytokines, amongst other effects [21, 22]. For
example, culture supernatant of Lactobacillus plantarum 2142
had a suppressive effect on the interleukin-8 (IL-8) and tumor
necrosis factor-𝛼 (TNF-𝛼) levels induced by oxidative stress
in IPEC-J2 cells [23].
The expression of heat shock proteins (HSPs), a set of
proteins that are involved in many regulatory pathways and
that serve as chaperones for preserving cellular proteins, can
be influenced by the intestinal microbiota and by probiotics
[24–26]. Some of these HSPs, such as the inducible form
of HSP70, are upregulated by several noxious conditions
and can therefore be considered as cellular stress indicators
[27]. HSPs and cytokines, in turn, are able to regulate
barrier properties by influencing tight junction proteins and
the structure and function of the cytoskeleton or transport
properties of the epithelium [24, 28].
In previous studies, feed supplementation with E. fae-
cium has been demonstrated to increase the absorptive and
secretory capacity and improve barrier function of the small
intestinal epithelium of piglets [29, 30]. Furthermore the
proinflammatory cytokine IL-1𝛼, which is expressed in higher
amounts in Peyer’s patches of E. faecium-treated piglets [31],
increases chloride secretion in the small intestine of pigs [29].
The hypothesis of the current study is that intestinal epi-
thelial cells play an important role in innate immune
responses during enteric infections and that E. faecium, in
turn, modulates the severity of enteric infections via the
altered generation of proinflammatory cytokines and HSPs
in intestinal cells. Thus, the aim of the present study has been
to investigate the influence of the probiotic E. faecium and
two different pathogenic E. coli strains on the HSP and proin-
flammatory cytokine responses and the epithelial integrity
of two intestinal epithelial cell lines. We have further tested
whether pre- and coincubation with E. faecium change the
epithelial cell response to pathogenic E. coli strains.
2. Materials and Methods
2.1. Cells and Culture Conditions. The cell cultivation is
described in detail in Lodemann et al. [32]. The human
epithelial intestinal cell line from colorectal adenocarcinoma,
Caco-2 (ATCC Catalog number HTB-37, ATCC, Manas-
sas, USA; passages 37–45), was used as a model for the
human small intestine. The porcine intestinal epithelial cell
line (IPEC-J2; passages 73–79) was used as a model for
the pig small intestine. This cell line was established from
the jejunum of a newborn pig [33] and kindly provided
by Professor Dr. Anthony Blikslager (North Carolina State
University, USA). The cells routinely tested negative for
mycoplasma contamination.
Cells for the experiments were allowed to differentiate for
14 days (IPEC-J2) or 21 days (Caco-2). On the day prior to
experiments, the cells were fed with serum- and antibiotic-
free media.
2.2. Bacterial Strains. Three different bacterial strains were
used for the experiments: (1) the probiotic strain Enterococ-
cus faecium NCIMB 10415 (cultivated from Cylactin, DSM,
Heerlen, the Netherlands), (2) the enterotoxigenic E. coli
IMT4818 (ETEC, isolated from a two-week-old piglet with
enteritis, O149:K91:K88 (F4), and found to be positive for the
presence of virulence genes est-1a, est-2 (genes coding for
heat stable enterotoxins I and II) and elt-1a/b (gene coding
for heat labile enterotoxin I) by the polymerase chain reaction
(PCR)), and (3) the human enteropathogenicE. coliE2348/69
(EPEC, serotypeO127:H6, positive for the eae gene coding for
the E. coli attaching-effacing factor).
The E. faecium NCIMB 10415 strain was cultivated in
brain-heart infusion (BHI) broth (OXOID GmbH, Wesel,
Germany) and the E. coli strains in LB medium according
to Miller, containing 10 g/L tryptone (OXOID GmbH, Wesel,
Germany), 5 g/L yeast extract (OXOID GmbH, Wesel, Ger-
many), and 10 g/L NaCl, at a pH of 7.0.
After overnight incubation of the cells at 37∘C, sub-
cultures of bacteria were grown for 3 to 4 h until mid-
log phase and then centrifuged. Cell pellets were washed
twice in phosphate-buffered saline (PBS, Biochrom, Berlin,
Germany). The bacteria were resuspended in antibiotic- and
serum-free Caco-2 or IPEC-J2 cell culture medium to reach
a concentration of ≈108 colony-forming units (CFU)/mL.
The optical density was measured to determine the con-
centration of bacterial cells.Themeasurement was confirmed
by serial dilution on agar plates. The intestinal cells were
infected with 106 bacteria per cell culture insert (1.12 cm2)
or per well (1.91 cm2), corresponding to a multiplicity of
infection (MOI) of about 10 bacteria per seeded cell. The
bacteria were added to the apical pole of the cells.
2.3. Experimental Setup and Procedure. For each experiment,
the cell monolayers for the real-time quantitative PCRs (RT-
qPCR), for enzyme-linked immunosorbent assay (ELISA),
and for the transepithelial electrical resistance (TER) mea-
surements were incubated for 2 hwith the respective bacterial
strains (ETEC, EPEC, or E. faecium) at a concentration of
106 bacteria per cell culture insert or well (see Figure 1). The
control cells received the equivalent amount of bacteria-free
medium. Two hours after the bacterial incubation, the cells
were washed twice with gentamicin-supplemented media to
wash out and kill the bacteria, and gentamicin-supplemented
media were added. Gentamicin was added to the media at
a concentration of 50𝜇g/mL (Biochrom, Berlin, Germany).
The cells were incubated for various periods of time with
regard to the different parameters measured, the exact time
periods being given in Figure 1 under the specific headings.
When the cells were incubated with the probiotic and either
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Figure 1: Timeline for the experimental setup.
the ETEC or the EPEC together, the cells were preincubated
with the E. faecium for 2 h, and then the pathogens were
added. The cells were in contact with the pathogens for the
same amount of time as in the monoincubation with the
ETEC or EPEC. In the following, this experimental setup will
be called “coincubation” and the incubation timewill be given
as the time that the cells were incubated with the pathogens.
A total of six independent experiments were performed
for each cell line.
2.4. Transepithelial Electrical Resistance (TER)Measurements.
For TER measurements, the cells were seeded at a density
of 105 cells on cell culture inserts (Transwell, clear polyester
membrane, 12mm diameter, 1.12 cm2 area, 0.4 𝜇m pore size;
Corning B.V., Schiphol-Rijk, the Netherlands).The inserts for
IPEC-J2 cells were coated with rat tail collagen type I (Serva
Electrophoresis GmbH, Heidelberg, Germany). TER was
measured by a Millicell-ERS (Electrical Resistance System;
Millipore GmbH, Schwalbach, Germany). TER values were
measured every two hours and corrected for the resistance of
blank filters and for the membrane area.
2.5. Real-Time Quantitative Polymerase Chain Reaction (RT-
qPCR). For determining mRNA expression, the cells were
seeded on 24-well cell culture plates (TPP, Biochrom, Berlin,
Germany) at a density of 105 cells/1.91 cm2. Confluent cell
monolayers were incubated with the bacterial strains as
described in the section “Experimental Setup.” After 4 h, cells
were washed two times with PBS, stored in RNAlater RNA
Stabilization Reagent (Qiagen GmbH, Hilden, Germany),
and frozen at −20∘C.
The isolation of the total RNA of the harvested cells,
the assessment of the RNA quality, and the cDNA synthesis
are described in detail in other publications [29, 32]. The
samples had to have a RNA integrity number above 7 to
be used for RT-qPCR. For the synthesis of cDNA, 100 ng
total RNA for the IPEC-J2 cells and 500 ng total RNA for
the Caco-2 cells were used. Primer information is given in
Table 1.Three reference geneswere selected for normalization
(ACTB, TBP, andUBP for the Caco-2 cells andGAPDH, TBP,
and YWHAZ for the IPEC-J2 cells). The primer information
for the reference genes can be found in Lodemann et al. [32].
RT-qPCR was performed and the relative amount of the
target genes in the experimental groups was calculated by iQ5
software (Bio-Rad Laboratories GmbH,Mu¨nchen, Germany)
as described in Klingspor et al. [29].
2.6. Enzyme-Linked Immunosorbent Assay (ELISA). For the
ELISA experiments, the cells were seeded on 24-well cell
culture plates (TPP, Biochrom, Berlin, Germany) at a density
of 105 cells/1.91 cm2, and incubation with bacterial strains
was as described above. After 8 h, the supernatants of the
cells were harvested, and species-specific IL-8 ELISAs were
performed on cell culture supernatants according to the
manufacturers’ instructions (Invitrogen ELISAKit, Swine IL-
8, Invitrogen Life Technologies GmbH,Darmstadt, Germany,
for IPEC-J2 supernatants; Thermo scientific human IL-8
ELISA Kit, Pierce Biotechnology, Rockford, USA, for Caco-
2 supernatants). Assays were performed in duplicate.
For the HSP70 ELISA, protein was extracted from the
cells. For this purpose, the Complete Lysis-M reagent set
(Roche Diagnostics Deutschland GmbH Mannheim, Ger-
many) was used, and the lysis buffer containing a mild deter-
gent in bicine buffer and protease inhibitors was prepared
following the manufacturers’ instructions. The cells were
washed with PBS, and 200𝜇L lysis buffer was added to each
well. After 5min of incubation at room temperature and
gentle shaking, the cell lysate was collected. HSP70 ELISA
of the extracted protein was performed according to the
manufacturers’ instructions (Porcine HSP70 ELISA Kit, Bio-
Medical Assay for IPEC-J2 cell extracts and HSP70 ELISA
Kit, StressMARQBiosciences forCaco-2 cell extracts). Assays
were performed in duplicate.
2.7. Statistical Analysis. Statistical evaluations were carried
out by means of the IBM SPSS-Statistics program for Win-
dows, version 22 (International Business Machines Corp.,
Armonk, United States of America). Graphs were plotted
with SPSS and Microsoft Excel 2010. Results are given as
means ± SEM.𝑁 refers to the number of experiments.
Statistical significance of differences was assessed by
variance analysis.The fixed factor was “treatment of the cells”
(incubationwithmedium (control),E. faecium, ETEC, EPEC,
ETEC or EPEC in coincubation with E. faecium). An overall
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Table 1: Oligonucleotide primers and amplicon length of PCR products.
Gene information Primer sequence Amplicon length Accession number Reference
HSP70
(heat shock protein 70, Homo
sapiens)
(S) 5󸀠-ACT GCC CTG ATC AAG CGC-3󸀠
(AS) 5󸀠-CGG GTT GGT TGT CGG AGT AG-3󸀠 81 bp NM 005346 [34]
IL8 (CXCL8)
(interleukin-8 (chemokine (C-X-C
motif) ligand 8), Homo sapiens)
(S) 5󸀠-ATG ACT TCC AAG CTG GC-3󸀠
(AS) 5󸀠-ACT TCT CCA CAA CCC T-3󸀠 274 bp NM 000584.3 [35]
HSP70
(heat shock protein 70, Sus scrofa)
(S) 5󸀠-GTG GCT CTA CCC GCA TCC C-3󸀠
(AS) 5󸀠-GCA CAG CAG CAC CAT AGG C-3󸀠 114 bp M29506 [36]
IL8 (CXCL8)
(interleukin-8, Sus scrofa)
(S) 5󸀠-GGC AGT TTT CCT GCT TTC T-3󸀠
(AS) 5󸀠-CAG TGG GGT CCA CTC TCA AT-3󸀠 154 bp X61151 [37]
analysis of the data for each cell line and each parameter
(TER, mRNA-, and protein expression) was performed. A 𝑃
value of <0.05 was assumed to indicate statistically significant
differences. If a statistical significant difference occurred in
the overall analysis each timepoint (4 h, 6 h, 8 h)was analyzed
separately. In the case of a significant difference between
groups (treatment of the cells), the Fisher least significant
difference post hoc test was performed.
3. Results
3.1. TER Measurements. The TER values of confluent cell
monolayers were recorded as ameasure of epithelial integrity.
3.1.1. Caco-2. The overall analysis revealed significant differ-
ences of TER between incubations with the various bacteria
(𝑃 < 0.001). Monoincubation of the cells with the probiotic
E. faecium caused an increase of TER compared with the
control (at 4 h; Figure 2) indicating a positive effect of E.
faecium on barrier function. Exposure of the cells to ETEC
significantly decreased TER (at 4 h and 6 h), whereas the TER
of EPEC-treated cells did not show significant alterations
compared with the control. Cell monolayers coincubated
with E. faecium and ETEC showed a significantly higher TER
compared with cells incubated with ETEC alone.
3.1.2. IPEC-J2. In IPEC-J2 cells, significant differences
between the various bacterial incubations could also be
detected (𝑃 = 0.01). In this cell line, the TER values were not
affected in cells that were incubated with E. faecium alone
compared with the control (Figure 3). However, the ETEC
strain, again, caused a significant decrease in TER (4 h, 6 h),
whereas the TER of cells incubated with EPEC did not differ
significantly from the control. Pre- and coincubation with
E. faecium reversed the decreased TER of ETEC-treated
IPEC-J2 cell monolayers at 4 h and, as a trend, at 6 h, while
TER of EPEC-treated cells was not changed by pre- and
coincubation with E. faecium.
3.2. HSP Expression. As a stress indicator for the pathogenic
challenge, HSP70 expression was tested in both cell lines at
the mRNA and protein levels.
3.2.1. Caco-2. In the overall analysis, the differences between
the treatment groups were statistically significant for the
mRNA expression of HSP70 (𝑃 = 0.001).
After four hours of incubation, no differences could be
observed between control cells and cells incubated with
EPEC or E. faecium (alone or in combination with ETEC
and EPEC) (Figure 4(a)). However, the mRNA expression
of HSP70 was significantly higher in the cells that were
incubated with the ETEC strain alone compared with all
other treatments.This implied that the coincubation of ETEC
with E. faecium significantly reduced the increase in mRNA
expression observed during incubation with ETEC alone.
These results were reflected by the changes in HSP70
protein expression (Figure 4(b)).
3.2.2. IPEC-J2. For IPEC-J2 cells, the mRNA and protein
expression of HSP70 showed some numerical, but no statis-
tically significant, differences between the treatment groups
(Figure 5).
3.3. IL-8 Expression. The cytokine IL-8 was chosen as a
measure of the proinflammatory response of the cells.
3.3.1. Caco-2. The bacterial incubation significantly affected
the mRNA expression of IL-8 (𝑃 = 0.008). The mRNA
expression of IL-8 did not differ between the cells incubated
with E. faecium and the control cells. However, it was
significantly increased 4 h after incubation with the ETEC
strain compared with the control and the E. faecium-treated
cells. Coincubation with E. faecium significantly reduced
this increase (Figure 6(a)). Although a numerical increase
was seen in all groups incubated with bacteria, the mRNA
expression did not differ significantly between the other
treatment groups and the control (Figure 6(a)).
The changes in mRNA expression were mirrored by
similar changes in IL-8 protein expression (Figure 6(b)).
3.3.2. IPEC-J2. The results regarding IL-8 expression by the
IPEC-J2 cell line were largely comparable with the results
obtained for Caco-2 cells. In the overall analysis, significant
differences for IL-8 mRNA (𝑃 = 0.001) and protein expres-
sion (𝑃 = 0.001) were observed, and statistical differences





































Figure 2: TER values of Caco-2 cells in percent of the initial value before the beginning of the experiment (𝑡 = 0 hours) (means ± SEM). Cell
monolayers were treated with various bacterial strains for 4 h and 6 h.𝑁 = 6 independent experiments; different letters indicate significant



































Coincubation with E. faecium
4 6
Figure 3: TER values of the IPEC-J2 cells in percent of the initial value before the beginning of the experiment (𝑡 = 0 hours) (means ±
SEM). Cell monolayers were treated with various bacterial strains for 4 h and 6 h.𝑁 = 6 independent experiments; different letters indicate
significant differences between the differently treated cells (𝑃 ≤ 0.05).
between individual groups were as described for Caco-2 cells
(Figure 7).
4. Discussion
The aim of this study was to elucidate the effects of the
probiotic E. faecium on barrier function and the inflamma-
tory response of the intestinal epithelium, the latter effect
being, in addition to other functions, an important part of the
immune system of the gut. To examine whether the probiotic
strain could modify the epithelial response to a pathogenic
challenge, epithelial cell monolayers were incubated with
two selected pathogenic E. coli strains. Our hypothesis
was that epithelial integrity might be improved, whereas
the expression of HSP70 and proinflammatory cytokines
might be reduced because of the action of E. faecium.
Such “challenge” experiments can be carried out in
various ways. One approach is to treat the confluent cell mon-
olayers directly with the pathogenic bacteria for the whole
duration of the experiment. The second is to incubate the
epithelial cells with supernatants of the bacterial cultures
[23, 38].The advantage of using supernatants is the avoidance
of pH decreases in the medium or nutrient competition by
the rapidly growing bacteria [39]. However, supernatants
or dead bacteria cannot mimic the conditions of living
bacteria and exclude potential direct interactions of living
bacteria with the epithelial cells. To include such bacteria-
epithelial interactions, the experimental design of the present






























































Coincubation with E. faecium
(b)
Figure 4: HSP70 expression in Caco-2 cells after treatment with various bacterial strains (means ± SEM). (a) mRNA expression, 𝑁 = 5
independent experiments and (b) protein expression, 𝑁 = 4 independent experiments; different letters indicate significant differences


















































Coincubation with E. faecium
(b)
Figure 5: HSP70 expression in IPEC-J2 cells after treatment with various bacterial strains (means ± SEM). (a) mRNA expression, 𝑁 = 6
independent experiments and (b) protein expression,𝑁 = 4 independent experiments.
study included an initial incubation with living bacteria for
2 h. Thereafter, bacteria were killed by gentamicin, with the
intention of diminishing secondary effects of the bacterial
incubation. Two intestinal epithelial cell lines were used:
porcine IPEC-J2 and human Caco-2 cells.
The Caco-2 cell line is well established and has been
used for many years to investigate specific aspects of small
intestinal function, including investigations on the effects of
probiotic bacteria [40, 41]. Nonetheless, it has limitations
because of its cancerogenic origin from the colon. The
porcine IPEC-J2 cells seem to be a suitable model to mimic
in vivo conditions of the small intestine, as they have no
tumorous origin and were originally isolated from the small
intestine [30, 42]; they have been recently used to study other
probiotic microorganisms [23, 39]. The second aim of this
study has therefore been to compareCaco-2 and IPEC-J2 cells
under the same experimental conditions to provide further
evidence for the use of IPEC-J2 cells as a model for small
intestinal simulation.
4.1. TER. TER is a compound measure of paracellular and
transcellular resistance and has been used to assess epithelial
integrity in probiotic studies [43, 44]. In the present study,
the TER of both cell lines was slightly increased after 4 h
























































Coincubation with E. faecium
(b)
Figure 6: IL-8 expression in Caco-2 cells after treatment with various bacterial strains (means ± SEM). (a) mRNA expression, 𝑁 = 5
independent experiments and (b) protein expression, 𝑁 = 5 independent experiments, different letters indicate significant differences



























































Coincubation with E. faecium
(b)
Figure 7: IL-8 expression in IPEC-J2 cells after treatment with various bacterial strains (means ± SEM). (a) mRNA expression, 𝑁 = 6
independent experiments and (b) protein expression, 𝑁 = 6 independent experiments; different letters indicate significant differences
between the differently treated cells (𝑃 ≤ 0.05).
of incubation with E. faecium alone, but significantly only
in Caco-2 cells. These results are in agreement with data
of earlier studies showing that various probiotic bacterial
strains had either no or an enhancing effect on the TER of
intestinal epithelial cells of various origins [45–47]. In porcine
IPEC-J2 cells, no enhancing effect has been reported so far
[23]. The ETEC strain but not the EPEC strain significantly
reduced TER in both cell lines compared with the control;
this indicates a change in the epithelial integrity as shown
previously by other authors [48, 49]. This decrease was
inhibited when cell monolayers were (pre- and) coincubated
with the E. faecium strain. Similar results have been obtained
for other probiotic strains in in vitro infection studies with
various intestinal cell lines of human origin, such as T84,
HT29, or Caco-2 cells [43, 44, 50]. In a porcine cell model
(IPEC-1) Lactobacillus sobrius DSM 16698 also inhibited the
decrease of TER caused by an ETEC strain [51].
In former studies, a probiotic action to prevent the TER
decrease induced by ETEC has been correlated with the
inhibition of E. coli adhesion, which is the first step of
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ETEC infection [52]. Another possibility by which E. faecium
could prevent the decrease of TER after ETEC infection
might be related to tight junction (TJ) protein expression and
localization or to the cytoskeletal organization [51].
These parameters have not been assessed here but will be
the target of further studies.
4.2. HSP70. HSPs protect cells, tissues, and organs against
various types of stress factors by reducing or avoiding the
stress-induced denaturation of proteins. Gene expression of
inducible HSP is triggered by many different stressors and
is mainly regulated at the transcriptional level [53–55]. In
the gastrointestinal tract, the expression of inducible HSP is
markedly influenced by the intestinal microbiota [56, 57].
The inducible form of HSP70, which was assessed in the
present study, is often considered to be cytoprotective as
its induction by minor stressors can protect the tissue from
major challenges [58, 59]. Some probiotic bacteria obviously
activate this cytoprotective mechanism as part of their mode
of action [23, 60, 61]. E. faecium alone, however, did not
alter expression of HSP70 in the present study, indicating
that different probiotics rely on different mechanisms and
pathways to exert their effects on the host [15, 60].
However, in the Caco-2 cells, the expression of HSP70
was significantly increased in the cells incubated with the
ETEC.This increase could be prevented by probiotic pre- and
coincubation. In the IPEC-J2 cells, a similar tendency could
be observed.
Although, as stated above, the upregulation of HSP70 is
often interpreted as a positive effect because of its cytoprotec-
tive effects, evidence has also been presented suggesting that
HSP70 expression is an indicator of pathological stress [27].
In conjunctionwith the effects onTER and the proinflam-
matory cytokine response, the increased expression ofHSP70
after pathogenic challenge indicates a stress reaction of the
intestinal cells. As such, the reduced increase in HSP70 after
pre- and coincubation with E. faecium in the present study
suggests that cells are less damaged by ETEC.
4.3. IL-8. The proinflammatory cytokine response in the
gastrointestinal tract is influenced by the gut microbiota.
Among others, the cytokine expression of epithelial cells
can be modulated by probiotic strains [21, 40, 62]. Altered
cytokine release, in turn, can regulate the structure and
function of TJ and cytoskeleton [63, 64] and the transport
properties of epithelial cells [65, 66].
In the present study, IL-8 has been chosen as a representa-
tive cytokine of the epithelial proinflammatory response. IL-
8 belongs to the proinflammatory “chemokine” family and is
reported to induce neutrophil and T-lymphocyte chemotaxis,
neutrophil activation, and the enhanced expression of neu-
trophil adhesion molecules [67, 68]. One of the responses of
intestinal epithelial cells as part of the innate immune system
to various inflammatory stimuli is the production of IL-8
[69].
In the present study, IL-8 expression was considerably
increased when the cells were incubated with ETEC; this
increase was abrogated by concomitant incubation with E.
faecium. Similar reductions of proinflammatory responses
to a pathogen by probiotic strains have been observed in
other in vivo and in vitro models [23, 41, 51, 70]. In some
cases, this was accompanied by the maintenance of epithelial
barrier function [70]. In porcine intestinal epithelial cells,
various lactobacilli and bacilli strains counteract the increase
in IL-8 and other proinflammatory cytokines elicited by
stimulation with ETEC, S. typhimurium, oxidative stress, or
lipopolysaccharide. In some cases, this is associated with the
protection of the epithelial barrier [23, 39, 71].
Although IL-8 secretion is part of the innate immune
response aimed at the elimination of pathogens, the persistent
production of IL-8 accompanied by the constant infiltra-
tion of neutrophils leads to massive epithelial cell damage
[72], which is one cause of diarrhea. Several studies have
demonstrated that epithelial damage can be prevented by
interventions that suppress the IL-8 levels in IBD [73, 74].
This could also be an approach for reducing epithelial damage
and diarrhea in acute infections such as ETEC and, here,
we consider it to be one of the positive effects of healthy
microbiota [61]. Taking this into account, the effects of E.
faecium observed in the present study indicate a protective
effect of this probiotic in acute intestinal inflammation
induced by ETEC.
The exact mechanisms by which E. faecium exerts its
influence on cytokine secretion have to be further investi-
gated.
5. Conclusion
Preincubation with the probiotic E. faecium abrogates or
reduces all examined effects induced by the ETEC such as
the HSP70 stress response, the elevated expression of the
proinflammatory cytokine IL-8, and the decrease in TER as
a measure of epithelial integrity.
A key feature of the intestinal immune system is its ability
to protect against pathogens while avoiding a destructive
inflammatory response. An exaggerated proinflammatory
cytokine secretion such as IL-8 leads to disease states and, in
this case, a reduction of proinflammatory cytokines together
with the reduction of HSP70 expression and the prevention
of potential epithelial damage might alleviate symptoms,
indicating a positive effect by the probiotic. The underlying
mechanisms will be the subject of further studies.
Both cell lines react in a similar manner to incubation
with pathogens and the probiotic. Therefore, the IPEC-J2
cell line can be considered as a reliable model for studying
the effects of probiotics on the protection of the intestinal
epithelium from stressful conditions and inflammation. Fur-
thermore, the parallel response in the two cell lines underlines
the general transferability of the effects of E. faecium seen in
the present study.
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